Join
Live feed
·
PRReleasevia Quantisnow
Viela Bio, Inc. logo

Viela Bio Announces Additional Positive Results with UPLIZNA® (inebilizumab-cdon) in Patients with Neuromyelitis Optica Spectrum Disorder at the ACTRIMS 2021 Forum

ByQuantisnow·Wall Street's wire, on your screen.
VIE· Viela Bio, Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VIE (Viela Bio, Inc.) and more on Quantisnow.